| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.04 |